CD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases

dc.creatorCanale, Fernando Pablo
dc.creatorRamello, María Cecilia
dc.creatorMontes, Carolina Lucia
dc.date.accessioned2020-01-27T21:36:09Z
dc.date.accessioned2022-10-15T08:37:05Z
dc.date.available2020-01-27T21:36:09Z
dc.date.available2022-10-15T08:37:05Z
dc.date.created2020-01-27T21:36:09Z
dc.date.issued2018-04
dc.identifierCanale, Fernando Pablo; Ramello, María Cecilia; Montes, Carolina Lucia; CD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases; Impact Journals; Oncoscience; 5; 3-4; 4-2018; 1-2
dc.identifier2331-4737
dc.identifierhttp://hdl.handle.net/11336/95929
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4365799
dc.description.abstractCD8+ T cells have long been considered crucial in the immune response against tumors. However, in the last decade a subpopulation of exhausted CD8+ T cells has been described which exhibit a dysfunctional phenotype and contribute to poor immune control of tumors and chronic viral infections...
dc.languageeng
dc.publisherImpact Journals
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.18632%2Foncoscience.404
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978445
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.impactjournals.com/oncoscience/index.php?issue=39
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.impactjournals.com/oncoscience/index.php?pii=404
dc.rightshttps://creativecommons.org/licenses/by/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCD39
dc.subjectInflamation
dc.subjectT cells
dc.subjectExhaution
dc.titleCD39 as a marker of pathogenic CD8+ T cells in cancer and other chronic inflammatory diseases
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución